Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
Angle recession glaucoma Indication Strategy Report 2026: Rho kinase, Trials and Deals
3 August 2026
2026 Angle recession glaucoma indication strategy covering epidemiology, Rho kinase biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Normal tension glaucoma Indication Strategy Report 2026: Rho kinase, Trials and Deals
3 August 2026
2026 Normal tension glaucoma indication strategy covering epidemiology, Rho kinase biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Plateau iris syndrome Indication Strategy Report 2026: Rho kinase, Trials and Deals
3 August 2026
2026 Plateau iris syndrome indication strategy covering epidemiology, Rho kinase biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Pigment dispersion syndrome Indication Strategy Report 2026: TYR, Trials and Deals
3 August 2026
2026 Pigment dispersion syndrome indication strategy covering epidemiology, TYR biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Pseudoexfoliation syndrome Indication Strategy Report 2026: LOXL1, Trials and Deals
3 August 2026
2026 Pseudoexfoliation syndrome indication strategy covering epidemiology, LOXL1 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Orbital lymphangioma Indication Strategy Report 2026: PIK3CA, Trials and Deals
3 August 2026
2026 Orbital lymphangioma indication strategy covering epidemiology, PIK3CA biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Thyroid eye disease chronic inactive Indication Strategy Report 2026: IGF1R, Trials and Deals
3 August 2026
2026 Thyroid eye disease chronic inactive indication strategy covering epidemiology, IGF1R biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Idiopathic orbital inflammation Indication Strategy Report 2026: CD20, Trials and Deals
3 August 2026
2026 Idiopathic orbital inflammation indication strategy covering epidemiology, CD20 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Dysthyroid optic neuropathy Indication Strategy Report 2026: IGF1R, Trials and Deals
3 August 2026
2026 Dysthyroid optic neuropathy indication strategy covering epidemiology, IGF1R biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Peripheral ulcerative keratitis Indication Strategy Report 2026: CD20, Trials and Deals
3 August 2026
2026 Peripheral ulcerative keratitis indication strategy covering epidemiology, CD20 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Posterior scleritis Indication Strategy Report 2026: TNF, Trials and Deals
3 August 2026
2026 Posterior scleritis indication strategy covering epidemiology, TNF biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Iridocorneal endothelial syndrome Indication Strategy Report 2026: VEGF, Trials and Deals
3 August 2026
2026 Iridocorneal endothelial syndrome indication strategy covering epidemiology, VEGF biology, active trials, transactions, unmet need, competition and market…